# Targeted Therapy With Glycogen Synthase Kinase-3 Inhibition for Arrhythmogenic Cardiomyopathy

Study · id `cardio:ct-nct06174220` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06174220](<https://clinicaltrials.gov/study/NCT06174220>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06174220

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems; Heart failure; Acute care and long-term living  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 120 participants.

## Technical summary

Registry record NCT06174220. Randomized; quadruple masking; primary purpose treatment. Start 2025-03-21 (actual); primary completion 2027-02-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 120 participants (planned count; ClinicalTrials.gov record NCT06174220, source copy `cardio:ctgov-nct06174220-2026-03-12`, retrieved 2026-10-26)
- Started: 2025-03-21 (actual) (ClinicalTrials.gov record NCT06174220, source copy `cardio:ctgov-nct06174220-2026-03-12`, retrieved 2026-10-26)
- Primary completion: 2027-02-01 (anticipated) (ClinicalTrials.gov record NCT06174220, source copy `cardio:ctgov-nct06174220-2026-03-12`, retrieved 2026-10-26)
- Completion: 2027-07-01 (anticipated) (ClinicalTrials.gov record NCT06174220, source copy `cardio:ctgov-nct06174220-2026-03-12`, retrieved 2026-10-26)
- Countries: Canada (ClinicalTrials.gov record NCT06174220, source copy `cardio:ctgov-nct06174220-2026-03-12`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06174220-2026-03-12`, retrieved 2026-10-26)

## The registry's words

- Brief title: Targeted Therapy With Glycogen Synthase Kinase-3 Inhibition for Arrhythmogenic Cardiomyopathy
- Acronym: TaRGET
- Condition: Arrhythmogenic Cardiomyopathy
- Condition: Arrhythmogenic Right Ventricular Cardiomyopathy
- Intervention (Drug): Tideglusib
- Intervention (Drug): Placebo
- Lead sponsor: Hamilton Health Sciences Corporation
- Lead sponsor class: OTHER
- Collaborator: Canadian Institutes of Health Research (CIHR)
- Collaborator class: OTHER\_GOV
- Collaborator: Canadian SADS
- Collaborator class: UNKNOWN
- Collaborator: AMO Pharma Limited
- Collaborator class: INDUSTRY
- Collaborator: Hearts in Rhythm Organization (HiRO)
- Collaborator class: UNKNOWN
- Collaborator: Population Health Research Institute
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Cardiomyopathy (heart muscle disease) (`cardio:cardiomyopathy`)
- Registry condition terms include this condition: Sudden cardiac arrest (`cardio:sudden-cardiac-arrest`)
- Registry lists this organization as the lead sponsor: Hamilton Health Sciences Corporation (`cardio:org-hamilton-health-sciences-corporation`)
- Registry lists this organization as a collaborator: Canadian Institutes of Health Research (CIHR) (`cardio:org-canadian-institutes-of-health-research-cihr`)
- Registry lists this organization as a collaborator: Population Health Research Institute (`cardio:org-population-health-research-institute`)

## Provenance

Content hash: 5b2880083c4ce9832e22ccd7a521279a26cb00be9b376f6395e730c8c92955fd
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
